Table 2.

Characteristics of patients who underwent EUS-hepaticojejunostomy and their outcomes (n=8)

Patient	Age (years)/sex	Underlying disease	Anatomy	Indication of EUS-HJS	Presence of cholangitis	Needle type	Diameter of IHBD (mm)	Procedure time (min)	Technical success	Adverse events
1	81/male	CBD stone	TGRY	Unsuccessful BE-ERCP	No	22G	3.0	35	Yes	No
2	74/female	CBD stone	TGRY	Unsuccessful BE-ERCP	No	22G	4.0	35	Yes	No
3	82/female	CBD stone	TGRY	Unsuccessful BE-ERCP	No	22G	2.2	15	Yes	No
4	79/female	CBD stone	TGRY	Unsuccessful BE-ERCP	No	19G	2.7	23	Yes	No
5	88/male	CBD stone	TGRY	Unsuccessful BE-ERCP	No	22G	5.7	45	Yes	No
6	68/male	CBD stone	TGRY	Unsuccessful BE-ERCP	No	22G	3.0	44	Yes	No
7	78/female	CBD stone	TGRY	Unsuccessful BE-ERCP	No	19G	4.2	10	Yes	No
8	78/male	CBD stone	TGRY	Unsuccessful BE-ERCP	No	19G	4.0	32	Yes	No

HJS: Hepaticojejunostomy; CBD: Common bile duct; TGRY: Total gastrectomy with Roux-en-Y reconstruction; BE-ERCP: Balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography; IHBD: Intrahepatic bile duct